Deformable and degradable nanozymes for inhaled viral pneumonia treatment

. 2025 Mar 25;6(1):103-105.

doi: 10.12336/biomatertransl.2025.01.008. eCollection 2025.

Affiliations

¹ Department of Chemistry, School of Chemistry and Materials, Laboratory of Advanced Materials and Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China.

Junfeng Song et al. Biomater Transl. 2025.

. 2025 Mar 25;6(1):103-105.

doi: 10.12336/biomatertransl.2025.01.008. eCollection 2025.

¹ Department of Chemistry, School of Chemistry and Materials, Laboratory of Advanced Materials and Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China.

No abstract available

Conflict of interest statement

Conflicts of interest statement: The authors declare no conflicts of interest.

1. Ruuskanen O., Lahti E., Jennings L., Murdoch D. Viral pneumonia. Lancet. 2011;377:1264–1275. doi:10.1016/S0140-6736(10)61459-6. - PMC - PubMed
1. Vigant F., Santos N., Lee B. Broad-spectrum antivirals against viral fusion. Nat Rev Microbiol. 2015;13:426–437. doi:10.1038/nrmicro3475. - PMC - PubMed
1. Jiang D., Ni D., Rosenkrans Z., Huang P., Yan X., Cai W. Nanozyme:New horizons for responsive biomedical applications. Chem Soc Rev. 2019;48:3683–3704. - PMC - PubMed
1. Wang H., Wan K., Shi X. Recent advances in nanozyme research. Adv Mater. 2019;31:e1805368. doi:10.1002/adma.201805368. - PubMed
1. Peng W., Tai W., Li B., et al. Inhalable nanocatalytic therapeutics for viral pneumonia. Nat Mater. 2024 doi:10.1038/s41563-024-02041-5. - PubMed